Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China

NCT01299077 is registered in ClinicalTrials.gov with Eisai China Inc. as lead sponsor.

NCT NCT01299077
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01299077 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar Disc Degenerative Disease in China
Lead sponsor
Eisai China Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
November 30, 2010
Enrollment
478 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

lumbar disc degenerative disease